BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26724931)

  • 21. Failure to suppress low-frequency neuronal oscillatory activity underlies the reduced effectiveness of random patterns of deep brain stimulation.
    McConnell GC; So RQ; Grill WM
    J Neurophysiol; 2016 Jun; 115(6):2791-802. PubMed ID: 26961105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of 5-HT
    Vegas-Suárez S; Aristieta A; Requejo C; Bengoetxea H; Lafuente JV; Miguelez C; Ugedo L
    Br J Pharmacol; 2021 Jun; 178(12):2516-2532. PubMed ID: 33686657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional correlates of exaggerated oscillatory activity in basal ganglia output in hemiparkinsonian rats.
    Brazhnik E; Novikov N; McCoy AJ; Cruz AV; Walters JR
    Exp Neurol; 2014 Nov; 261():563-77. PubMed ID: 25084518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilateral subthalamic nucleus lesion reverses L-dopa-induced motor fluctuations and facilitates dyskinetic movements in hemiparkinsonian rats.
    Marin C; Jiménez A; Tolosa E; Bonastre M; Bové J
    Synapse; 2004 Feb; 51(2):140-50. PubMed ID: 14618681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Entopeduncular lesions facilitate and thalamic lesions depress spontaneous and drug-evoked motor behavior in the hemiparkinsonian rat.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 2001 Jun; 40(3):215-24. PubMed ID: 11304759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deep brain stimulation of the pedunculopontine tegmental nucleus modulates neuronal hyperactivity and enhanced beta oscillatory activity of the subthalamic nucleus in the rat 6-hydroxydopamine model.
    Alam M; Heissler HE; Schwabe K; Krauss JK
    Exp Neurol; 2012 Jan; 233(1):233-42. PubMed ID: 22036687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal activity in the medial associative-limbic and lateral motor part of the rat subthalamic nucleus and the effect of 6-hydroxydopamine-induced lesions of the dorsolateral striatum.
    Lindemann C; Alam M; Krauss JK; Schwabe K
    J Comp Neurol; 2013 Oct; 521(14):3226-40. PubMed ID: 23787707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The network of causal interactions for beta oscillations in the pedunculopontine nucleus, primary motor cortex, and subthalamic nucleus of walking parkinsonian rats.
    Li M; Zhou M; Wen P; Wang Q; Yang Y; Xiao H; Xie Z; Li X; Wang N; Wang J; Luo F; Chang J; Zhang W
    Exp Neurol; 2016 Aug; 282():27-36. PubMed ID: 27163550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bursting activity of substantia nigra pars reticulata neurons in mouse parkinsonism in awake and anesthetized states.
    Lobb CJ; Jaeger D
    Neurobiol Dis; 2015 Mar; 75():177-85. PubMed ID: 25576395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subthalamic nucleus activity in the awake hemiparkinsonian rat: relationships with motor and cognitive networks.
    Delaville C; McCoy AJ; Gerber CM; Cruz AV; Walters JR
    J Neurosci; 2015 Apr; 35(17):6918-30. PubMed ID: 25926466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early decreases in cortical mid-gamma peaks coincide with the onset of motor deficits and precede exaggerated beta build-up in rat models for Parkinson's disease.
    Brazhnik E; Novikov N; McCoy AJ; Ilieva NM; Ghraib MW; Walters JR
    Neurobiol Dis; 2021 Jul; 155():105393. PubMed ID: 34000417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in the firing activity of serotonergic neurons in the dorsal raphe nucleus in a rat model of Parkinson's disease.
    Zhang QJ; Gao R; Liu J; Liu YP; Wang S
    Sheng Li Xue Bao; 2007 Apr; 59(2):183-9. PubMed ID: 17437041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson's disease.
    Marin C; Bonastre M; Mengod G; Cortés R; Rodríguez-Oroz MC; Obeso JA
    Exp Neurol; 2013 Dec; 250():304-12. PubMed ID: 24140562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cross-hemispheric nigrostriatal pathway prevents the expression of levodopa-induced dyskinesias.
    Iyer V; Venkiteswaran K; Savaliya S; Lieu CA; Handly E; Gilmour TP; Kunselman AR; Subramanian T
    Neurobiol Dis; 2021 Nov; 159():105491. PubMed ID: 34461264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered neuronal activity relationships between the pedunculopontine nucleus and motor cortex in a rodent model of Parkinson's disease.
    Aravamuthan BR; Bergstrom DA; French RA; Taylor JJ; Parr-Brownlie LC; Walters JR
    Exp Neurol; 2008 Oct; 213(2):268-80. PubMed ID: 18601924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats.
    Martinez AA; Morgese MG; Pisanu A; Macheda T; Paquette MA; Seillier A; Cassano T; Carta AR; Giuffrida A
    Neurobiol Dis; 2015 Feb; 74():295-304. PubMed ID: 25486547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease.
    Ko WK; Martin-Negrier ML; Bezard E; Crossman AR; Ravenscroft P
    Neurobiol Dis; 2014 Oct; 70():138-48. PubMed ID: 24969021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levodopa/benserazide microsphere (LBM) prevents L-dopa induced dyskinesia by inactivation of the DR1/PKA/P-tau pathway in 6-OHDA-lesioned Parkinson's rats.
    Xie CL; Wang WW; Zhang SF; Yuan ML; Che JY; Gan J; Song L; Yuan WE; Liu ZG
    Sci Rep; 2014 Dec; 4():7506. PubMed ID: 25511986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain state-dependent alterations of corticostriatal synchronized oscillations in awake and anesthetized parkinsonian rats.
    Jiang X; Yan Y; Wang K; Wei J; Su W; Jia J
    Brain Res; 2019 Aug; 1717():214-227. PubMed ID: 31026456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in primary motor cortex neurotransmission and gene expression in hemi-parkinsonian rats with drug-induced dyskinesia.
    Lindenbach D; Conti MM; Ostock CY; Dupre KB; Bishop C
    Neuroscience; 2015 Dec; 310():12-26. PubMed ID: 26363150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.